Connection
Ashley Brooks-Russell to Cannabinoids
This is a "connection" page, showing publications Ashley Brooks-Russell has written about Cannabinoids.
|
|
Connection Strength |
|
 |
|
 |
|
0.957 |
|
|
|
-
Kosnett MJ, Ma M, Dooley G, Wang GS, Friedman K, Brown T, Henthorn TK, Brooks-Russell A. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):355-362.
Score: 0.767
-
Rague JM, Ma M, Dooley G, Wang GS, Friedman K, Henthorn TK, Brooks-Russell A, Kosnett MJ. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):363-369.
Score: 0.190